You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AMED scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AMED ($117.21) is undervalued by 6.57% relative to our estimate of its Fair Value price of $125.45 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AMED ($117.21) is not significantly undervalued (6.57%) relative to our estimate of its Fair Value price of $125.45 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
(NASDAQ: AMED) AMEDISYS trades on the NASDAQ under the ticker symbol AMED. AMEDISYS stock quotes can also be displayed as NASDAQ: AMED.
What is the 52 week high and low for AMEDISYS (NASDAQ: AMED)?
(NASDAQ: AMED) AMEDISYS's 52-week high was $276.21, and its 52-week low was $109.53. It is currently -57.56% from its 52-week high and 7.02% from its 52-week low.
How much is AMEDISYS stock worth today?
(NASDAQ: AMED) AMEDISYS currently has 32,572,820 outstanding shares. With AMEDISYS stock trading at $117.21 per share, the total value of AMEDISYS stock (market capitalization) is $3.82B.
AMEDISYS stock was originally listed at a price of $3.38 in Dec 31, 1997. If you had invested in AMEDISYS stock at $3.38, your return over the last 24 years would have been 3,372.89%, for an annualized return of 15.93% (not including any dividends or dividend reinvestments).
How much is AMEDISYS's stock price per share?
(NASDAQ: AMED) AMEDISYS stock price per share is $117.21 today (as of May 24, 2022).
What is AMEDISYS's Market Cap?
(NASDAQ: AMED) AMEDISYS's market cap is $3.82B, as of May 25, 2022.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
AMEDISYS's market cap is calculated by multiplying AMED's current stock price of $117.21 by AMED's total outstanding shares of 32,572,820.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.